Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2010 Feb;61(2):139-44.
doi: 10.1007/s00105-009-1841-y.

[Axillary hyperhidrosis--efficacy and tolerability of an aluminium chloride antiperspirant. Prospective evaluation on 20 patients with idiopathic axillary hyperhidrosis]

[Article in German]
Affiliations
Clinical Trial

[Axillary hyperhidrosis--efficacy and tolerability of an aluminium chloride antiperspirant. Prospective evaluation on 20 patients with idiopathic axillary hyperhidrosis]

[Article in German]
M Streker et al. Hautarzt. 2010 Feb.

Abstract

Background: The purpose of this study was to evaluate the efficacy and tolerability of aluminium chloride gel for treatment of axillary hyperhidrosis.

Patients and methods: A total of 20 patients aged 22-38 (mean age: 26.9+/-4.3) with idiopathic axillary hyperhidrosis were included and treated with an antiperspirant (Sweat-off, Sweat-off GmbH, Hügelsheim). Study duration was 42 days. Treatment efficacy was evaluated clinically, as well as by starch-iodine test, gravimetric analysis and evaluation of the skin surface pH.

Results: After treatment there was a significant clinical improvement accompanied by significant qualitative and quantitative reduction of sweat as well as a significant reduction of skin surface pH. Except for slight skin irritation in 6 patients, there were no other side effects. Patient satisfaction improved markedly during the study.

Conclusion: Treatment of axillary hyperhidrosis with aluminium chloride is an effective, safe and inexpensive treatment modality.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Br J Dermatol. 1998 Dec;139(6):1123-4 - PubMed
    1. Eur J Vasc Endovasc Surg. 2004 Jun;27(6):571-6 - PubMed
    1. Br J Dermatol. 1984 Apr;110(4):399-403 - PubMed
    1. Dermatologica. 1980;161(2):133-5 - PubMed
    1. Mayo Clin Proc. 2005 May;80(5):657-66 - PubMed

Publication types

LinkOut - more resources